Definium Therapeutics, Inc. Proceeds from Issuance of Warrants
Definium Therapeutics, Inc. (DFTX) reported Proceeds from Issuance of Warrants of $17.75 million for the 12-month period ending 2022-12-31, per its 10-K filed 2024-02-28.
Discontinued › Cash Flow
us-gaap:ProceedsFromIssuanceOfWarrants · last filed 2024-02-28
- Definium Therapeutics, Inc. proceeds from issuance of warrants for the quarter ending 2022-12-31 was $0.00.
- Definium Therapeutics, Inc. proceeds from issuance of warrants for fiscal 2022 was $17.75M.
| Period end | Proceeds from Issuance of Warrants 3 month | Proceeds from Issuance of Warrants 9 month | Proceeds from Issuance of Warrants 12 month |
|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $17.75M 10-K · filed 2024-02-28 | |
| 2022-09-30 | $17.75M 10-Q · filed 2023-11-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cronos Group Inc. (CRON) | $1.223B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B |